REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aspironix Polska Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Miscellaneous Store Retailers | Warehousing and Storage | Lessors of Real Estate | Automotive Equipment Rental and Leasing | Commercial and Industrial Machinery and Equipment Rental and Leasing | Advertising Agencies | Marketing Research and Public Opinion Polling | Repair and Maintenance
Full name: Aspironix Polska Sp. z o.o. Profile Updated: October 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Aspironix is a company that develops and utilizes Boston Scientific products for the treatment of male incontinence and erectile dysfunction. Aspironix's target market is in the healthcare industry.

Headquarters
Ul. Rozyckiego 3
Krakow; Malopolskie; Postal Code: 31-324

Contact Details: Purchase the Aspironix Polska Sp. z o.o. report to view the information.

Website: http://www.aspironix.com

Basic Information
Total Employees:
Purchase the Aspironix Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Aspironix Polska Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Aspironix Polska Sp. z o.o. report to view the information.
Incorporation Date:
August 07, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
W Organie Czlonek Zarzadu Reprezentujacym
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Aspironix Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
18.37%▲
Total operating revenue
18.67%▲
Operating profit (EBIT)
329.16%▲
EBITDA
268.46%▲
Net Profit (Loss) for the Period
253.85%▲
Total Assets
27.14%▲
Total Equity
97.64%▲
Operating Profit Margin (ROS)
11.81%▲
Net Profit Margin
9%▲
Return on Equity (ROE)
21.81%▲
Quick Ratio
0.49%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo